Fundraising Fox
Aplagon
Helsinki, FI · 7 known investors
Find your way into Aplagon
Sign up to see every warm intro you have to Aplagon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aplagon team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics targeting thromboinflammatory and cardiovascular diseases. The company's lead candidate, APAC, is a heparin proteoglycan mimetic currently in clinical trials.
Founders & leadership
Investors · 7
FSGlisted by FSGLund · $1.1M – $6.5M
How we know: FSG's portfolio page · finance.yahoo.com · Not right? Tell us
Innovestor Ventureslisted by Innovestor VenturesHelsinki · $270K – $3.2M
How we know: Innovestor Ventures's portfolio page · Not right? Tell us
InnovestorreportedFinland
How we know: finance.yahoo.com · Not right? Tell us
Also in the syndicate · 3
European Innovation Council (EIC) FundleadGösta Serlachius Fine Arts FoundationJenny and Antti Wihuri Foundation
Frequently asked questions
- What does Aplagon do?
- Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics targeting thromboinflammatory and cardiovascular diseases. The company's lead candidate, APAC, is a heparin proteoglycan mimetic currently in clinical trials.
- Who founded Aplagon?
- Aplagon was founded by Sakari Lassila.
- Who are Aplagon's investors?
- Aplagon's investors include FSG, Innovestor Ventures, Invesdor, Innovestor.
- Where is Aplagon headquartered?
- Aplagon is headquartered in Helsinki, FI.